# BilT-02 (NCT03639935)

> Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum Therapy

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03639935
- Phase: PHASE2
- Status: COMPLETED
- Sponsor: University of Michigan Rogel Cancer Center
- Conditions: Biliary Tract Cancer
- Interventions: Rucaparib; Nivolumab
- Enrollment: 32
- Primary outcome: Proportion of Patients Alive and Without Radiological or Clinical Progression at 4 Months

## Indexed commentary on BilT-02 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 5

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=bilt-02-nct03639935